Profile 751psg1037_2.7.11.13


Profile informations:

Profile AC

PRI218163

Profile ID

751psg1037_2.7.11.13

Profile linked activities

Protein kinase C. (EC 2.7.11.13);

Number of sequences in that profile

16

Most frequent protein names

KPCA KPCG 

Profile length

118

E-value threshold

3E-42

Bit-score threshold

167.5

 


Graphic representation of enzymes containing that profile:
KPCB_XENLA 587psg1037_2.7.11.13: 1-159 751psg1037_2.7.11.13: 160-277 1790psg1037_2.7.11.13: 278-337 1psg1037_2.7.11.13: 338-515 18psg1037_2.7.11.13: 517-565 131psg1037_2.7.11.13: 572-629 794psg1037_2.7.11.13: 637-663
KPCG_HUMAN 587psg1037_2.7.11.13: 1-161 751psg1037_2.7.11.13: 165-280 3867psg1037_2.7.11.13: 281-356 1psg1037_2.7.11.13: 357-535 21psg1037_2.7.11.13: 536-594 131psg1037_2.7.11.13: 596-646 794psg1037_2.7.11.13: 654-681
KPCG_RAT 587psg1037_2.7.11.13: 1-161 751psg1037_2.7.11.13: 165-280 3867psg1037_2.7.11.13: 281-356 1psg1037_2.7.11.13: 357-535 21psg1037_2.7.11.13: 536-594 131psg1037_2.7.11.13: 596-646 794psg1037_2.7.11.13: 654-681
KPCA_RABIT 587psg1037_2.7.11.13: 1-162 751psg1037_2.7.11.13: 163-280 1790psg1037_2.7.11.13: 281-344 1psg1037_2.7.11.13: 345-518 21psg1037_2.7.11.13: 519-570 131psg1037_2.7.11.13: 572-629 794psg1037_2.7.11.13: 637-664
KPCA_RAT 587psg1037_2.7.11.13: 1-162 751psg1037_2.7.11.13: 163-280 1790psg1037_2.7.11.13: 281-344 1psg1037_2.7.11.13: 345-518 21psg1037_2.7.11.13: 519-570 131psg1037_2.7.11.13: 572-629 794psg1037_2.7.11.13: 637-664
KPCA_MOUSE 587psg1037_2.7.11.13: 1-162 751psg1037_2.7.11.13: 163-280 1790psg1037_2.7.11.13: 281-344 1psg1037_2.7.11.13: 345-518 21psg1037_2.7.11.13: 519-570 131psg1037_2.7.11.13: 572-629 794psg1037_2.7.11.13: 637-664
KPCB_XENTR 587psg1037_2.7.11.13: 1-159 751psg1037_2.7.11.13: 160-277 1790psg1037_2.7.11.13: 278-337 1psg1037_2.7.11.13: 338-515 18psg1037_2.7.11.13: 517-565 131psg1037_2.7.11.13: 572-629 794psg1037_2.7.11.13: 637-663
KPCG_MACFA 587psg1037_2.7.11.13: 1-161 751psg1037_2.7.11.13: 165-280 3867psg1037_2.7.11.13: 281-356 1psg1037_2.7.11.13: 357-535 21psg1037_2.7.11.13: 536-594 131psg1037_2.7.11.13: 596-646 794psg1037_2.7.11.13: 654-681
KPC1_LYTPI 587psg1037_2.7.11.13: 8-153 751psg1037_2.7.11.13: 155-271 8616psg1037_2.7.11.13: 272-330 1psg1037_2.7.11.13: 331-501 21psg1037_2.7.11.13: 503-563 131psg1037_2.7.11.13: 565-616 794psg1037_2.7.11.13: 624-649
KPC1_APLCA 587psg1037_2.7.11.13: 3-146 751psg1037_2.7.11.13: 148-264 8616psg1037_2.7.11.13: 265-325 1psg1037_2.7.11.13: 326-496 18psg1037_2.7.11.13: 497-549 131psg1037_2.7.11.13: 557-617 794psg1037_2.7.11.13: 619-646
KPCA_HUMAN 587psg1037_2.7.11.13: 1-162 751psg1037_2.7.11.13: 163-280 1790psg1037_2.7.11.13: 281-344 1psg1037_2.7.11.13: 345-518 18psg1037_2.7.11.13: 519-565 131psg1037_2.7.11.13: 572-629 794psg1037_2.7.11.13: 637-664
KPCA_BOVIN 587psg1037_2.7.11.13: 20-162 751psg1037_2.7.11.13: 163-280 1790psg1037_2.7.11.13: 281-344 1psg1037_2.7.11.13: 345-518 21psg1037_2.7.11.13: 519-570 131psg1037_2.7.11.13: 572-629 794psg1037_2.7.11.13: 637-664
KPC1_DROME 14848psg1037_2.7.11.13: 1-22 587psg1037_2.7.11.13: 23-180 751psg1037_2.7.11.13: 181-298 17373psg1037_2.7.11.13: 299-345 1psg1037_2.7.11.13: 346-529 18psg1037_2.7.11.13: 530-577 131psg1037_2.7.11.13: 588-645 794psg1037_2.7.11.13: 648-676
KPCG_RABIT 587psg1037_2.7.11.13: 1-161 751psg1037_2.7.11.13: 165-280 3867psg1037_2.7.11.13: 281-356 1psg1037_2.7.11.13: 357-535 21psg1037_2.7.11.13: 536-594 131psg1037_2.7.11.13: 596-646 794psg1037_2.7.11.13: 654-681
KPCG_MOUSE 587psg1037_2.7.11.13: 1-161 751psg1037_2.7.11.13: 165-280 3867psg1037_2.7.11.13: 281-356 1psg1037_2.7.11.13: 357-535 21psg1037_2.7.11.13: 536-594 131psg1037_2.7.11.13: 596-646 794psg1037_2.7.11.13: 654-681
KPC2_DROME 14850psg1037_2.7.11.13: 1-51 587psg1037_2.7.11.13: 52-197 751psg1037_2.7.11.13: 199-315 17375psg1037_2.7.11.13: 316-369 1psg1037_2.7.11.13: 370-547 18psg1037_2.7.11.13: 550-601 131psg1037_2.7.11.13: 608-661 794psg1037_2.7.11.13: 669-700


For information, comments and / or suggestions on PRIAM,
please email us at PRIAM Team